TSHA – taysha gene therapies, inc. (US:NASDAQ)
Stock Stats
News
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $6.00 to $8.00. They now have a "buy" rating on the stock.
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $7.00 price target on the stock.
Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ... [Yahoo! Finance]
Taysha Gene Therapies, Inc. (TSHA) Q3 2024 Earnings Call Transcript [Seeking Alpha]
Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
Form SC 13G/A Taysha Gene Therapies, Filed by: Venrock Healthcare Capital Partners III, L.P.
Form SC 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Form SC 13G Taysha Gene Therapies, Filed by: Avoro Capital Advisors LLC
Form 10-Q Taysha Gene Therapies, For: Sep 30
Form 8-K Taysha Gene Therapies, For: Nov 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.